Nabihah Tayob

机构：Harvard University, Breast Cancer Research Foundation, Dana-Farber Cancer Institute, Consorci Institut D'Investigacions Biomediques August Pi I Sunyer · ORCID：0000-0001-6088-167X

发表论文 449 篇 · 总被引 5787 次 · h-index 38

代表论文

• Efficacy, safety, and predictive biomarkers of neoadjuvant nab-paclitaxel and pembrolizumab in hormone receptor-positive breast cancer: A randomized pilot trial (2025 · Nature Communications · 被引 5)
• TRADE: tolerability of adjuvant abemaciclib at 6 months after initial dose escalation in patients with early-stage HR-positive/HER2-negative breast cancer (2026 · ESMO Open · 被引 1)
• Association of immune and proliferation gene signatures and stromal tumor-infiltrating lymphocytes with clinical outcomes in patients with stage I triple-negative breast cancer (2026 · European Journal of Cancer)
• TLSB-19 CENTRAL NERVOUS SYSTEM DISSEMINATION IN METASTATIC LOBULAR BREAST CANCER: A HISTOLOGY-BASED ANALYSIS (2026 · Neuro-Oncology Advances)
• Patient-reported outcomes from the TBCRC 022 study of neratinib and ado-trastuzumab emtansine for HER2-positive breast cancer brain metastases (2026 · The Breast)
• Avutometinib, Abemaciclib, and Fulvestrant in Patients with HR+/HER2− Metastatic Breast Cancer Previously Treated with CDK4/6 Inhibitor: A Single-Arm Phase I Trial (2026 · Clinical Cancer Research)